Genomic determinants of leptin expression
Genomic determinants of leptin expression
批准号:
7487482
负责人:
Evan D Rosen
金额:
$24.99万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2010-08-31
关键词:
AddressAdipocytesAdipose tissueAffectAreaBone DensityCellsClinicalDataDeoxyribonuclease IDeoxyribonucleasesDesire for foodElectrophoretic Mobility Shift AssayEndocrine GlandsGene Transfer TechniquesGenesGeneticGenomicsHistonesHormonesHypersensitivityLeptinLipodystrophyMapsMessenger RNANon-Insulin-Dependent Diabetes MellitusNutritionalObesityPathway interactionsPhysiological ProcessesPlayRNA InterferenceRangeReporterReproductionRoleScreening procedureSignal TransductionTherapeuticTissuesTrans-Activatorsadipokinesbaseblood glucose regulationchromatin immunoprecipitationglucose toleranceimmune functioninnovationinnovative technologiesinsightinterestsmall hairpin RNAsuccess
中文摘要
描述(由申请人提供):肥胖和2型糖尿病的巨大影响要求我们更好地理解代谢活性组织如何解释和整合营养信号。特别是,有新发现的认识,脂肪组织作为一种内分泌器官,负责协调广泛的稳态机制。第一个被发现的脂肪源性激素(所谓的“脂肪因子”)是瘦素,由Lep基因编码,或多或少具有脂肪选择性。目前已知瘦素通过调节食欲起到脂肪抑制作用,并且还在葡萄糖稳态、免疫功能、生殖和骨密度中起主要作用。提高瘦素水平是脂肪代谢障碍和某些遗传性肥胖症的有效治疗策略,并可能有助于常见肥胖症的一部分。尽管有这些临床意义和大量的基础科学兴趣瘦素,几乎没有什么是已知的转录途径,调节瘦素mRNA的合成。在这里,我们提出了一些创新的方法来解决这个长期存在的问题。例如,我们已经使用BAC转基因来进行脂肪细胞选择性Lep表达所需区域的粗略定位,并取得了巨大成功。第一个Aim使用额外的BAC转基因轮次来进一步减少靶区域。第二个目的是通过高通量DNA酶超敏反应作图、修饰组蛋白的染色质免疫沉淀和电泳迁移率变动分析来精细地定位关键的顺式区域。第三个目标是通过在Lep报告细胞中进行有限的RNAi筛选来鉴定影响Lep表达的反式作用因子。总之,这些研究将提供巨大的洞察Lep脂肪细胞表达的转录基础。瘦素是一种脂肪细胞来源的激素,除了对其他生理过程包括骨密度、生殖和免疫功能的影响外,还对食欲和葡萄糖耐量具有深远的影响。尽管经过了十年的深入研究,但几乎没有关于调节瘦素合成的关键转录途径的数据。该提案使用各种创新技术来解决这一缺陷,包括BAC转基因,高通量DNase超敏性分析和shRNA筛选。
英文摘要
DESCRIPTION (provided by applicant): The enormous impact of obesity and type 2 diabetes demands that we develop a better understanding of how nutritional signals are interpreted and integrated by metabolically active tissues. In particular, there is newfound appreciation that adipose tissue serves as an endocrine organ with responsibility for coordinating a wide range of homeostatic mechanisms. The first of the adipose-derived hormones (the so-called 'adipokines') to be discovered was leptin, encoded by the Lep gene in a more or less adipose-selective manner. Leptin is now known to serve an adipostatic role by regulating appetite, and also plays a major role in glucose homeostasis, immune function, reproduction, and bone density. Raising leptin levels is a useful therapeutic strategy in lipodystrophy and in some genetic forms of obesity, and may be helpful in a subset of common obesity. Despite these clinical implications and the enormous amount of basic scientific interest in leptin, virtually nothing is known about the transcriptional pathways that regulate leptin mRNA synthesis. Here we propose several innovative approaches to solving this longstanding problem. For example, we have used BAC transgenesis to perform gross mapping of the regions required for adipocyte-selective Lep expression with great success. The first Aim uses additional rounds of BAC transgenesis to further reduce the target area. The second Aim allows fine mapping of critical cis regions through high- throughput DNase hypersensitivity mapping, chromatin immunoprecipitation of modified histone, and electrophoretic mobility shift assays. The third Aim is directed at identifying trans-acting factors that affect Lep expression through a limited RNAi screen in Lep reporter cells. Taken together, these studies will provide enormous insight into the transcriptional basis of Lep adipocyte expression. Leptin is an adipocyte-derived hormone with profound effects on appetite and glucose tolerance, in addition to effects on other physiological processes including bone density, reproduction, and immune function. Despite a decade of intensive study, there are virtually no data on the critical transcriptional pathways that regulate leptin synthesis. This proposal uses a variety of innovative technologies to address this deficit, including BAC transgenesis, high-throughput DNase hypersensitivity analysis, and shRNA screening.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomics and Bioinformatics Core
-
批准号:10586206
-
项目类别:
-
资助金额:$10.96万
-
财政年份:2023
-
负责人:Evan D Rosen
-
依托单位:
Regulation of Adipose-Lymphatic Cross-talk
-
批准号:10295061
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2021
-
负责人:Evan D Rosen
-
依托单位:
Regulation of Adipose-Lymphatic Cross-talk
-
批准号:10612923
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2021
-
负责人:Evan D Rosen
-
依托单位:
Regulation of Adipose-Lymphatic Cross-talk
-
批准号:10451587
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2021
-
负责人:Evan D Rosen
-
依托单位:
TGFbeta-mediated Transcriptional Reprogramming of Mature Adipocytes in Obesity
-
批准号:9326420
-
项目类别:
-
资助金额:$54.7万
-
财政年份:2017
-
负责人:Evan D Rosen
-
依托单位:
Role of IRF3 in Energy and Glucose Homeostasis
-
批准号:10117360
-
项目类别:
-
资助金额:$67.02万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Role of IRF3 in Energy and Glucose Homeostasis
-
批准号:9043054
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Role of IRF3 in Energy and Glucose Homeostasis
-
批准号:9212138
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Transcriptional Mechanisms of Human Insulin Resistance
-
批准号:10337205
-
项目类别:
-
资助金额:$63.75万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Role of IRF3 in Energy and Glucose Homeostasis
-
批准号:10477318
-
项目类别:
-
资助金额:$66.19万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Role of IRF3 in Energy and Glucose Homeostasis
-
批准号:10264168
-
项目类别:
-
资助金额:$66.22万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Transcriptional Mechanisms of Human Insulin Resistance
-
批准号:9902418
-
项目类别:
-
资助金额:$64.29万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Role of IRF3 in Energy and Glucose Homeostasis
-
批准号:10689208
-
项目类别:
-
资助金额:$59.1万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
A Causal Role for Nuclear Receptor Pathways in Insulin Resistance
-
批准号:8907298
-
项目类别:
-
资助金额:$46.98万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
A Causal Role for Nuclear Receptor Pathways in Insulin Resistance
-
批准号:9212143
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
Transcriptional Mechanisms of Human Insulin Resistance
-
批准号:10088438
-
项目类别:
-
资助金额:$64.05万
-
财政年份:2015
-
负责人:Evan D Rosen
-
依托单位:
REGULATION OF NUTRIENT HOMEOSTASIS BY IRF4
-
批准号:8446454
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2010
-
负责人:Evan D Rosen
-
依托单位:
Regulation of Nutrient Homeostasis by IRF4
-
批准号:8837927
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2010
-
负责人:Evan D Rosen
-
依托单位:
REGULATION OF NUTRIENT HOMEOSTASIS BY IRF4
-
批准号:8247856
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2010
-
负责人:Evan D Rosen
-
依托单位:
REGULATION OF NUTRIENT HOMEOSTASIS BY IRF4
-
批准号:8636012
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2010
-
负责人:Evan D Rosen
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: